Genetic and Clinical Features of Progranulin-Associated Frontotemporal Lobar Degeneration
Open Access
- 11 April 2011
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 68 (4), 488-497
- https://doi.org/10.1001/archneurol.2011.53
Abstract
Frontotemporal lobar degeneration (FTLD) is the second most common cause of dementia in individuals younger than 65 years.1 Clinically, patients develop prominent changes in behavior, language, or both.2-4This publication has 42 references indexed in Scilit:
- Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer diseaseNeurology, 2008
- Loss of progranulin function in frontotemporal lobar degenerationTrends in Genetics, 2008
- A novel deletion in progranulin gene is associated with FTDP-17 and CBSNeurobiology of Aging, 2008
- Variations in the progranulin gene affect global gene expression in frontotemporal lobar degenerationHuman Molecular Genetics, 2008
- Molecular characterization of novel progranulin (GRN) mutations in frontotemporal dementiaHuman Mutation, 2008
- Missense Mutations in the Progranulin Gene Linked to Frontotemporal Lobar Degeneration with Ubiquitin-immunoreactive Inclusions Reduce Progranulin Production and SecretionPublished by Elsevier BV ,2008
- Progranulin locus deletion in frontotemporal dementiaHuman Mutation, 2007
- Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C→T (Arg493X) mutation: an international initiativeThe Lancet Neurology, 2007
- Corticobasal Syndrome Associated With the A9D Progranulin MutationJournal of Neuropathology and Experimental Neurology, 2007
- Alzheimer and Parkinson Diagnoses in Progranulin Null Mutation Carriers in an Extended Founder FamilyArchives of Neurology, 2007